Updated on 16 July 2013
He added that GSK takes a large portion of the profits from its drug sales in China to bribe government officials, medical associations, hospitals and doctors. Expenses for bribery are ultimately being covered by the public.
In its statement, the company clarified, "GSK shares the desire of the Chinese authorities to root out corruption. These allegations are shameful and we regret this has occurred."